Upcoming Stock Splits for August 18-22: Salarius, Entero, Chanson, LanzaTech, GIBO

Several companies are undergoing stock splits this week, including Salarius Pharmaceuticals, Entero Therapeutics, Chanson International Holding, LanzaTech Global, and GIBO Holdings. These splits are either traditional or reverse, aimed at broadening a stock's accessibility or maintaining compliance with exchange rules.

Several companies are undergoing stock splits this week, including Salarius Pharmaceuticals, Entero Therapeutics, Chanson International Holding, LanzaTech Global, and GIBO Holdings. These splits are either traditional or reverse, aimed at broadening a stock's accessibility or maintaining compliance with exchange rules.

Salarius Pharmaceuticals (NASDAQ: SLRX) announced a 1-for-15 reverse stock split, set to take effect at 5:00 p.m. Eastern Time on August 15, 2025. This move is intended to regain compliance with the $1.00 minimum closing bid price required for continued listing on the Nasdaq Capital Market. The reverse stock split will reduce the number of shares from approximately 7.6 million to approximately 509,000 shares [2].

Entero Therapeutics (NASDAQ: ENTR) is also undergoing a reverse stock split, with details yet to be announced. Chanson International Holding (NASDAQ: CHAN) and LanzaTech Global (NASDAQ: LTCH) are expected to follow suit with their own stock splits in the coming weeks. GIBO Holdings (NASDAQ: GIBO) has not yet disclosed specific details about its upcoming stock split.

Reverse stock splits are a common strategy used by companies to increase the price per share, potentially making the stock more attractive to investors. However, they can also dilute the number of shares outstanding, which can affect the overall value of the company. Investors should carefully consider the implications of these splits before making any investment decisions.

References:
[1] AInvest. (2025, August 17). Cardano ADA Breaks Downtrend Hints At 176 Rally. https://www.ainvest.com/news/cardano-ada-breaks-downtrend-hints-176-rally-1-84-2508/
[2] Salarius Pharmaceuticals. (2025, August 14). Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split. https://www.biospace.com/press-releases/salarius-pharmaceuticals-announces-1-for-15-reverse-stock-split